In an As2O3-induced NASH model, researchers found that taurine (Tau) inhibits pyroptosis and attenuates hepatic inflammation through inhibition of the cathepsin B (CTSB)–NLRP3 inflammatory vesicle pathway [103]. Here, CTSB is linked to metabolic dysfunction-associated steatohepatitis.